Key result
Lower cerebral vascular collagen-IV is linked to worse small vessel disease severity, independent of hypertension.
Why the study?
It was hypothesized that increased vascular collagen-IV associates with clinical hypertension and SVD in older persons and with chronic hypertension in primates and rats.
Does clinical or experimental hypertension and sporadic cerebral small vessel disease associate with altered vascular collagen-IV levels in small cerebral arteries across humans, non-human primates, and rats?
Cohort (n=52)
Harvesting of TIFF files and all image analyses were performed blind to clinical data
Adult male M mulatta were randomized either to undergo aortic narrowing to induce chronic severe hypertension or to remain unoperated (normotensive controls)
Yes
Does clinical or experimental hypertension and sporadic cerebral small vessel disease associate with altered vascular collagen-IV levels in small cerebral arteries across humans, non-human primates, and rats?
Sporadic cerebral small vessel disease is associated with insufficient rather than excessive arterial basement membrane collagen-IV alongside fibrillar collagen I and III remodeling, while chronic hypertension does not alter vascular collagen-IV levels across humans, primates, or rats.
Answers are grounded in this paper and cite their sources.
Supports collagen-IV deficiency in SVD independent of hypertension; leaves open causal role and therapeutic targeting.
Background: Cerebral small vessel disease (SVD) is common in older people and causes lacunar stroke and vascular cognitive impairment. Risk factors include old age, hypertension and variants in the genes COL4A1/COL4A2 encoding collagen alpha-1(IV) and alpha-2(IV), here termed collagen-IV, which are core components of the basement membrane. We tested the hypothesis that increased vascular collagen-IV associates with clinical hypertension and with SVD in older persons and with chronic hypertension in young and aged primates and genetically hypertensive rats. Methods: We quantified vascular collagen-IV immunolabeling in small arteries in a cohort of older persons with minimal Alzheimer pathology (N=52; 21F/31M, age 82.8±6.95 years). We also studied archive tissue from young (age range 6.2–8.3 years) and older (17.0–22.7 years) primates ( M mulatta ) and compared chronically hypertensive animals (18 months aortic stenosis) with normotensives. We also compared genetically hypertensive and normotensive rats (aged 10–12 months). Results: Collagen-IV immunolabeling in cerebral small arteries of older persons was negatively associated with radiological SVD severity (ρ: −0.427, P =0.005) but was not related to history of hypertension. General linear models confirmed the negative association of lower collagen-IV with radiological SVD ( P <0.017), including age as a covariate and either clinical hypertension ( P <0.030) or neuropathological SVD diagnosis ( P <0.022) as fixed factors. Reduced vascular collagen-IV was accompanied by accumulation of fibrillar collagens (types I and III) as indicated by immunogold electron microscopy. In young and aged primates, brain collagen-IV was elevated in older normotensive relative to young normotensive animals ( P =0.029) but was not associated with hypertension. Genetically hypertensive rats did not differ from normotensive rats in terms of arterial collagen-IV. Conclusions: Our cross-species data provide novel insight into sporadic SVD pathogenesis, supporting insufficient (rather than excessive) arterial collagen-IV in SVD, accompanied by matrix remodeling with elevated fibrillar collagen deposition. They also indicate that hypertension, a major risk factor for SVD, does not act by causing accumulation of brain vascular collagen-IV.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2022) conducted a cohort in Cerebral small vessel disease (SVD) and hypertension (n=52). Radiological cerebral small vessel disease (SVD) severity and clinical history of hypertension vs. Absence of hypertension / neuropathological SVD and normotensive animal controls was evaluated on Vascular collagen-IV immunolabeled area fraction (%) in cerebral small penetrating arteries (Spearman ρ -0.427, p=0.005). Vascular collagen-IV immunolabeling in cerebral small arteries was negatively associated with radiological SVD severity and unrelated to hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: